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Abstract: Anaphylaxis is a serious life-threatening allergic reaction. Any medication may potentially trigger anaphylaxis,
but reaction to pantoprazole is rare. Our case is a 21 year-old girl with anaphylactic reaction to pantoprazole a
short time after prescription.
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1. Introduction
Pantoprazole is one of the proton pump inhibitor agents,
which was first introduced in 1994. Pantoprazole and other
proton pump inhibitors (PPIs) reduce acid production and
its indications are treatment of erosive gastritis, esophagitis,
gastric ulcer, duodenal ulcer and Zollinger Ellison syndrome
(1). Many side effects have been reported following panto-
prazol usage but it has rarely been reported as a cause of ana-
phylaxis. Here, we present a case of anaphylactic reaction to
intravenous pantoprazole in a young woman who had pre-
sented to emergency department following epigastric pain.
2. Case presentation:
The case is a 21-year-old woman who was brought
to emegency department of Amiralmomenin Hospital,
Maragheh, Iran, with epigastric pain, which had started 2
days before. The pain was localized, did not radiated to any-
where, and was slightly relived with eating and exacerbated
after half an hour. She did not have bloody vomit or Melena.
She had loose defecation three times a day. Vital signs were
as follow: blood pressure = 80/120 mmHg, heart rate = 72
beat/minute, respiratory rate = 14 beat/minute, and arterial
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oxygen saturation =94% in room air.
After careful history taking and clinical examination, the pa-
tient was diagnosed as gastritis. Intravenous line was ac-
cessed and she was treated with 40 mg intravenous panto-
prazole. 2 minutes after drug administration, the patient was
symptomatic with hives, dyspnea and cyanosis and her blood
pressure had decreased to 85/60 mmHg, heart rate increased
to 101/minute, and oxygen saturation to 78% in room air.
She was immediately treated as anaphylactic shock with nor-
mal saline (30cc/kg), intramuscular epinephrine (0.3 mg), in-
teravenous hydrocortisone (100 mg) and chlorpheniramin (4
mg). 6 lit/minute oxygen was administered via an oxygen
mask. Gradually, her general condition improved and after 2
hours, the general condition completely was recovered. She
was discharged after 12 hours.
3. Discussion
Several complications such as headache, dizziness, joint
pain, nausea, vomiting, abdominal pain, increased risk of
stomach and pancreatic cancer, acute interstitial nephritis,
diarrhea, risk of fractures, vitamin B 12 deficiency, hypomag-
nesaemia, fever, hypertensive pneumonitis, liver damage, se-
vere acute hepatitis, Kounis syndrome and thrombocytope-
nia have been reported following usage of PPIs (1-10). Acute
and delayed allergic reactions and systemic reactions have
been reported in rare cases, even with oral doses of pump in-
hibitor drugs (11-14). There are occasional cross-reactions
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between different drugs in this group (14). Our search in
literature shows that a few cases of anaphylaxis to PPI have
been reported (14-16), and our case is another report of ana-
phylaxis to pantoprazole. Anaphylatic reaction to PPIs is re-
ported with both oral and IV routes of administration (17, 18).
Hou-Chuan Lai et al. presented a case of anaphylaxis to IV
pantoprazole in a 50 year-old male patient during general
anesthesia, who was discharged after successful resuscita-
tion (19).
V. Vovolis et al. in a study in 2008 showed that skin test with
PPIs could be considered as an accurate and simple method
of evaluating the cross reaction between drugs of this group
(20).
Anaphylactic reaction to PPIs is rare but, like other causes of
anaphylactic shock, it is life treatining. It seems that emer-
gency phycisians should be aware of this problem and take
care of the patients in case of this reaction happening.
3.1. Discussion
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